Article metrics
PDF
Other content recommended for you
- Nice and not so nice
- National Institute for Clinical Excellence and its value judgments
- A cost-effectiveness comparison of the NICE 2015 and WHO 2013 diagnostic criteria for women with gestational diabetes with and without risk factors
- Cost-effectiveness of first-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy
- Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
- Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses
- NICE and neurology
- Wickedness or folly? The ethics of NICE’s decisions
- Screening for postnatal depression in primary care: cost effectiveness analysis
- The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk